FDA approves genetic test to help some colon cancer patients, physicians considering Erbitux therapy
The U.S. Food and Drug Administration today approved the first genetic test that can help some colorectal cancer (CRC) patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the presence of a gene mutation.
